key: cord-0839654-aw15dsal
authors: Graudenzi, Alex; Maspero, Davide; Angaroni, Fabrizio; Piazza, Rocco; Ramazzotti, Daniele
title: Mutational signatures and heterogeneous host response revealed via large-scale characterization of SARS-CoV-2 genomic diversity
date: 2021-01-28
journal: iScience
DOI: 10.1016/j.isci.2021.102116
sha: fdd86526050525e821ab5ac650d24e16e4952bdc
doc_id: 839654
cord_uid: aw15dsal

To dissect the mechanisms underlying the inflation of variants in the SARS-CoV-2 genome, we present a large-scale analysis of intra-host genomic diversity, which reveals that most samples exhibit heterogeneous genomic architectures, due to the interplay between host-related mutational processes and transmission dynamics. The decomposition of minor variants profiles unveils three non-overlapping mutational signatures related to nucleotide substitutions and likely ruled by APOBEC, Reactive Oxygen Species and ADAR, highlighting heterogeneous host responses to SARS-CoV-2 infections. A corrected-for-signatures dN/dS analysis demonstrates that such mutational processes are affected by purifying selection, with important exceptions. In fact, several mutations appear to transit toward clonality, defining new clonal genotypes that increase the overall genomic diversity. Furthermore, the phylogenomic analysis shows the presence of homoplasies and supports the hypothesis of transmission of minor variants. This study paves the way for the integrated analysis of intra-host genomic diversity and clinical outcome of SARS-CoV-2 infections.

The COVID-19 pandemic has currently affected 216 countries and territories worldwide with ≈ 70 million people being infected, while the number of casualties has reached the impressive number of ≈ 1.6 million (World Health Organization (WHO) (2020), update 15 December 2020). The origin and the main features of SARS-CoV-2 evolution have been investigated (Zhou et al., 2020b; Wu et al., 2020; Andersen et al., 2020; Xiao et al., 2020; Deng et al., 2020) , also due to the impressive amount of consensus viral sequences included in public databases, such as GISAID (Shu and McCauley, 2017) . However, only a few currently available datasets include raw sequencing data, which are necessary to quantify intra-host genomic variability.

Due to the combination of high error and replication rates of viral polymerase, subpopulations of viruses with distinct genotypes, also known as viral quasispecies (Domingo et al., 1985) , usually coexist within single hosts. Such heterogeneous mixtures are supposed to underlie most of the adaptive potential of RNA viruses to internal and external selection phenomena, which are related, e.g., to the interaction with the host's immune system or to the response to antiviral agents. For instance, it was hypothesized that intra-host heterogeneity may be correlated with prognosis and clinical outcome (Novella et al., 1995; Domingo et al., 2012) . Furthermore, even if the modes of transmission of intra-host variants in the population are still elusive, one may hypothesize that, in certain circumstances, infections allow such variants to spread, sometimes inducing significant changes in their frequency (Lythgoe et al., 2020) .

In particular, several studies on SARS-CoV-2 support the presence of intra-host genomic diversity in clinical samples and primary isolates (Ramazzotti et al., 2020; Shen et al., 2020; Wölfel et al., 2020; Capobianchi et al., 2020; Rose et al., 2020; Lu et al., 2020; Lythgoe et al., 2020; Seemann et al., 2020; Popa et al., 2020) , whereas similar results were obtained on SARS-CoV (Xu et al., 2004) , MERS (Park et al., 2016) , EBOLA (Ni et al., 2016) and H1N1 influenza (Poon et al., 2016) . We here present one of the the largest up-to-date studies on intra-host genomic diversity of SARS-CoV-2, based on a large dataset including 1133 high-quality samples for which raw sequencing data are available (NCBI BioProject: PRJNA645906). The results were validated on 4 independent datasets including a total of 953 samples (PRJNA625551, PRJNA633948, PRJNA636748, PRJNA647529; see the Validation section).

Our analysis shows that ≈ 15% of the SARS-CoV-2 genome has already mutated in at least one sample, including ≈ 1% of positions exhibiting multiple mutations. The large majority of samples shows a heterogeneous intra-host genomic composition, with 892 out of 1133 samples (≈ 79%) exhibiting at least one low frequency variant (variant frequency, VF > 5% and ≤ 90%, named minor variants or iSNVs), 171 samples more than 5 and 101 samples more than 10. Importantly, several variants are observed as clonal (VF > 90%) in certain samples and at a low frequency in others, demonstrating that transition to clonality might be due not only to functional selection shifts, but also to complex transmission dynamics involving bottlenecks and founder effects (Domingo et al., 2012) .

Strikingly, our analysis allowed to identify three non-overlapping mutational signatures, i.e., specific distributions of nucleotide substitutions,n which are observed in distinct mixtures and with significantly different intensity in three wellseparated clusters of samples, suggesting the presence of host-related mutational processes. One might hypothesize that such processes are related to the interaction of the virus with the host's immune system, and might pave the way for a better understanding of the molecular mechanisms underlying different clinical outcomes.

In particular, the first signature is dominated by C>T:G>A substitution and is likely related to APOBEC activity, the second signature is mostly characterized by G>T:C>A substitution and might be associated to ROS-related processes, while a third signature is predominantly associated to A>G:T>C substitution, which is usually imputed to ADAR activity. A corrected-for-signatures version of the dN/dS analysis would suggest that, as expected, the three signatures are affected by mild purifying selection in the population, yet with some exceptions that would suggest the existence of positively selected genomic regions. Furthermore, a certain proportion of samples of two signature-based clusters, mostly associated to APOBEC and ROS appear to be hypermutated (up to 87 minor variants detected in a single host), whereas this effect is mitigated for the remaining cluster, dominated by ADAR-related processes.

Finally, the analysis of the phylogenetic model, obtained from the profiles of clonal variants via VERSO (Ramazzotti et al., 2020) , allowed us to assess how many minor variants are either detected in single samples, in multiple samples of the same clade, or in multiple samples of independent clades (i.e., homoplasies). Strikingly, an approximately monotonic decrease of the median variant frequency is observed with respect to the number of clades in which minor variants are observed: minor variants detected in single clades exhibit the largest (median) variant frequency, as opposed to variants shared in multiple clades, which display a progressively lower variant frequency.

On the one hand, this result supports the hypothesis of transmission of minor variants during infections, and of the concurrent existence of bottleneck effects (Gutierrez et al., 2012; Domingo et al., 2012) . On the other hand, the significant number of minor variants observed at a low frequency in multiple clades would suggest the presence of mutational hotspots and of phantom mutations related to sequencing artifacts (Bandelt et al., 2002) .

The distribution of the number of minor and clonal variants observed in each sample (Fig. 1A) unveils an approximately normal distribution of clonal variants (median = 13, mean = 13.2 and max = 24). Minor variants are detected in ≈ 78.7% of the samples and show a long-tail distribution (median = 2, mean = 4.16 and max = 87). 109 samples (≈ 9.6% of the dataset) display a number of minor variants ≥ 10, up to a maximum of 87.

Interestingly, we observe a statistically significant increase of genomic diversity on clonal variants with respect to collection week (Mann-Kendall test for trend on median number of clonal variants p < 0.001, Fig. 1B) , due to the accumulation of clonal variants in the population, and which confirms recent findings Shen et al., 2020; Ramazzotti et al., 2020) , whereas, as expected, this phenomenon is less evident for minor variants (Fig. 1C ). This aspect is further investigated in the following and hints at the interplay involving the evolutionary dynamics within hosts and the transmission among hosts, which differently affects clonal and minor variants (Chan et al., 2013) .

Evidence of transition to clonality. We further categorize each detected SNV as: (i) always clonal, if clonal in all samples in which it is detected, (ii) always minor, if minor in all samples in which it is detected, (iii) mixed, if observed as clonal in at least one sample and as minor in at least another sample.

4677 single-nucleotide variants were detected on 4476 distinct genome sites (≈ 14.9% of the SARS-CoV-2 genome), of which 199 sites (≈ 0.6% of the genome) display multiple nucleotide substitutions (see Fig. 1D ). This suggests that the proportion of mutated genomic sites might be considerably higher in the overall population, especially if considering minor variants. Overall, 25.8%, 7.8% and 66.3% SNVs are detected as always clonal, mixed and always minor, and are mostly non-synonymous (see Fig. 1E -F).

The analysis of the VF distribution ( Fig. 1G ) unveils an impressive scarcity of variants showing VF in the middle-range, i.e., between 20% and 90%, for all categories. This phenomenon is likely due to transmission bottlenecks, which tend to purify low-frequency variants in the population. Nonetheless, both mixed and always minor variants display broad VF spectra, an aspect that is particularly relevant for the former category. In this respect, 24.4% of all mixed variants (89 on 365) never display a VF ≤ 20%: one may hypothesize that such variants are indeed transiting to clonality in the population, because either positively selected, as a result of the strong immunologic pressure within human hosts (Lucas et al., 2001) , or because affected by transmission phenomena involving founder effects, bottlenecks and stochastic fluctuations (Gutierrez et al., 2012; Domingo et al., 2012) .

Conversely, one might hypothesize that most remaining mixed variants may result from random mutations hitting positions of SNVs that are already present as clonal in the population.

Furthermore, the distribution of SNVs with respect to each region of the genome in Fig. 2A demonstrate that mutations are approximately uniformly distributed across the genome (also see Supplementary Fig. S2 ). Overall, this analysis provides one of the first large-scale quantifications of transition to clonality in SARS-CoV-2 and might serve to intercept variants possibly involved in functional modifications, bottlenecks or founder effects.

De novo inference of SARS-CoV-2 mutational signatures. In order to investigate the existence of mutational processes related to the interaction between the host and the SARS-CoV-2 virus, we analyzed the distribution of nucleotide substitutions for all SNVs detected in the dataset. In Fig. 2B one can see the proportion of SNVs for each of the 12 nucleotide substitution types (e.g., number of C>T's) over the total number of nucleotides present in the reference genome for each substitution type (e.g., number of C's).

Certain substitutions present a significantly higher normalized abundance, confirming recent findings on distinct cohorts (Simmonds, 2020; Di Giorgio et al., 2020; Popa et al., 2020) . In particular, C>T substitutions are observed in ≈ 28% of all C nucleotides in the SARS-CoV-2 genome; G>T's in ≈ 15% of all G's, T>C's in ≈ 7% of all T's, and A>G's in ≈ 5% of all A's.

Although, traditionally, a 12-substitution pattern has been used in order to report mutations occurring in single-stranded genomes, we reasoned that, owing to the intrinsically double-stranded nature of the viral life-cycle (i.e., a mutation occurring on a plus strand can be transferred on the minus strand by RdRP and vice versa) it is sound to consider a total of 6 substitution classes (obtained by merging equivalent substitutions in complementary strands) to investigate the possible presence of viral mutational signatures (Alexandrov et al., 2013) . Clonal variants were not considered in the next analyses, to focus on SNVs likely related to host-specific mutational processes and by excluding variants presumably transmitted during infection events.

In particular, in order to identify and characterize the mutational processes underlying the emergence of SARS-CoV-2 variants with a statistically grounded approach, we applied a Non-Negative Matrix Factorization (NMF) approach (Brunet et al., 2004) and standard metrics to determine the optimal rank (see Methods). In particular, we analyzed the mutational profiles of 150 samples exhibiting at least 6 always minor variants (on 1133 total samples), to ensure a sufficient sampling of the distributions.

J o u r n a l P r e -p r o o f Strikingly, 3 distinct and non-overlapping mutational signatures are found and explain 96.5% of the variance in the data ( Fig. 3A and Supplementary Fig. S4 ; Cophenetic correlation coefficient = 0.998, Cosine similarity between predictions and observations = 0.973, harmonic mean p-value of the one-sided Mann-Whitney U test on bootstrap re-sampling < 0.01 for all signatures, see Methods). In particular, signature S#1 is predominantly related to substitution C>T:G>A (81.2%), signature S#2 to substitution C>A:G>T (77.7%), while signature S#3 is dominated by substitutions T>C:A>G (60.7%) and T>A:A>T (23.6%).

Characterization of mutational signatures of SARS-CoV-2. Signature S#1 is related to C>T:G>A substitution, which was often associated to APOBEC (Apolipoprotein B mRNA Editing Catalytic Polypeptide-like), i.e., a cytidine deaminase involved in the inhibition of several viruses and retrotransposons (Sharma et al., 2015) . An insurgence of APOBEC-related mutations was observed in other coronaviruses shortly after spillover (Woo et al., 2007) and it was recently hypothesized that APOBEC-like editing processes might have a role in the response of the host to SARS-CoV-2 (Simmonds, 2020).

As specified above, a mutational process occurring on single-stranded RNA with a given pattern, e.g., C>T, could occur as a C>T mutation on the plus reference strand, but could similarly occur on the minus strand, again as a C>T substitution. However, C>T events originally occurring in the minus strand would be recorded as G>A owing to the mapping of the mutational event as a reverse-complement on the plus reference genome. Starting from these considerations and hypothesizing that the C>T:G>A substitution is mediated by APOBEC, which operates on singlestranded RNA and is similarly active on both strands, the analysis of the C>T / G>A ratio (or, more generally, of a plus/minus substitution ratio) should give an accurate measurement of the molar ratio between the two viral strands inside the infected cells.

In our case, by comparing the proportion of substitutions of all minor variants detected in the dataset, the ratio C>T / G>A is 5.1 1602/5491 335/5863 . This result allows us to hypothesize that plus and minus viral strands of the SARS-CoV-2 genome are present in infected cells with a molar ratio in strong favor of the plus strand, and are consistent with the expected activity of APOBEC on single-stranded RNA. Further experimental analyses will be required to confirm this hypothesis.

The second signature S#2 is predominantly characterized by substitution C>A:G>T, whose origin is however still obscure. To gain insight into the mechanisms responsible for its onset, also in this case we analyzed the C>A and G>T substitution frequency, which revealed a strong disproportion in favor of the latter: the ratio G>T / C>A is 9.5 804/5863 79/5491 . Overall, this results suggests that, in this case, the G>T substitution is the active mutational process.

In this respect, one might hypothesize a role for Reactive Oxygen Species (ROS) as mutagenic agent underlying this signature, as observed for instance in clonal cancer evolution (Alexandrov et al., 2020) . ROS are extremely reactive species formed by the partial reduction of oxygen. A large number of ROS-mediated DNA modifications have already been identified; in particular however, guanine is extremely vulnerable to ROS, because of its low redox potential (David et al., 2007) . ROS activity on guanine causes its oxidation to 7,8-dihydro-8-oxo-2 -deoxyguanine (oxoguanine). Notably: (i) oxoguanine can pair with adenine, ultimately causing G>T transversions, and (ii) ROS are able to operate on single-stranded RNA, therefore their mutational process closely resembles the C>A:G>T pattern we see in signature S#2. Thus, it is sound to hypothesize that the C>A:G>T substitution is generated by ROS, whose production is triggered upon infection, in line with several reports indicating that a strong ROS burst is often triggered during the early phases of several viral infections (Molteni et al., 2014; Reshi et al., 2014) .

Finally, signature S#3 is primarily characterized by A>G:T>C substitution, which is typically imputed to the ADAR deaminase mutational process (Nishikura, 2010) . ADAR targets adenosine nucleotides, causing deamination of the adenine to inosine, which is structurally similar to guanine, ultimately leading to an A>G substitution. Unlike APOBEC, ADAR targets double-stranded RNA, hence it is active only on plus/minus RNA dimers. In line with this mechanism and in sharp contrast with APOBEC, A>G's and the equivalent T>C's show a similar prevalence: the ratio A>G / T>C is 0.81 384/8954 508/9595 . This supports the notion that the A>G:T>C mutational process is exquisitely selective for double-stranded RNA, where it can similarly targets adenines present on both strands.

Identification of signature-based clusters. We then clustered the 150 samples with at least 6 always minor mutations (on 1133 total samples), by applying k-means on the normalized low-rank latent NMF matrix and employing standard heuristics to determine the optimal number of clusters (see Methods). As a result, 3 signature-based clusters (SC#1, SC#2 and SC#3) are retrieved, including 61, 49 and 40 samples respectively (see Fig. 3B ).

Remarkably, clusters SC#1 and SC#3 are characterized by distinctive signatures, S#1 (dominated by substitution C>T:G>A) and S#3 (T>C:A>G and T>A:A>T), respectively, whereas cluster SC#2 is characterized by a mixtures 4 J o u r n a l P r e -p r o o f of all three signatures. In particular, the samples of the distinct clusters display dissimilar categorical VF distributions (see Fig. 3D ), pointing at the existence of different host-related mutational processes. We here recall that samples with a number of always minor variants between 1 and 5 (742 samples, 65.5%) cannot be reliably associated to signature-based clusters, due to the low number of SNVs. For this reason, such samples were considered separately in the analysis and were labeled as cluster SC#4 from now on (Fig. 3C) .

Importantly, by computing the categorical VF distribution of all minor SNVs with respect to all 96 trinucleotide contexts (i.e., by considering flanking bases), one can notice that clusters SC#1 and SC#2 display profiles that resemble that of the theoretical substitution distribution of the reference genome, thus suggesting that, in such cases, the host-related mutational processes are likely independent from flanking bases. Conversely, SC#3 displays a distribution of T substitutions with prevalent peaks in certain contexts and, especially, in G[T>A]G, A[T>C]G and C[T>G]T.

We finally note that, due to the possible transmission of minor variants among hosts during infections (see above), signature-based clusters might include both samples with host-related mutational processes and samples with minor variants herited from infecting hosts.

Characterization of signature-based clusters. We analyzed in-depth the intra-host genomic diversity of the samples of the 4 different signature-based clusters. As a first noteworthy result, while the distributions of the number of clonal variants are significantly alike across clusters (Kolmogorov-Smirnov, KS test p > 0.20 for 6/6 pairwise comparisons; see In particular, clusters SC#1 and SC#2 are characterized by a significantly higher number of minor variants (median 16 and 18, mean 22.3 and 22.6, max 87 and 70, for SC#1 and SC#2, respectively). Accordingly, both clusters include a certain proportion of highly mutated samples (with ≥ 10 minor variants), 44 on 61 and 41 on 49 for SC#1 and SC#2, respectively. This result supports the existence of highly active mutational processes and is consistent with the hypothesis of processes related to APOBEC and ROS. Conversely, cluster SC#3 displays a much lower number of minor variants (median 11, mean 13.2, max 33; 23 samples on 40 with ≥ 10 variants). This finding hints at the existence of milder spontaneous mutational processes related to ADAR.

Interestingly, the VF distribution for all SNVs highlights a remarkable similarity among signature clusters SC#1, SC#2 and SC#3, with the large majority of variants found either at a high or a low frequency, whereas, by construction, SC#4 is dominated by clonal variants (Fig. 4C) . Moreover, only minor differences are observed in the distribution of substitutions with respect to SARS-CoV-2 Open Reading Frames (ORFs) (see Supplementary Fig. S3 ).

Overall, these results reinforce the hypothesis of distinct mutational processes active in different hosts. When clinical data would be available in combination to sequencing data, this will allow to assess the correlation with clinical outcomes.

Evidence of purifying selection against signature-related mutagenic processes. To investigate the evolutionary dynamics of SARS-CoV-2, we implemented a corrected-for-signatures version of the dN/dS ratio analysis, i.e., obtained by normalizing the S/NS rate with respect to the theoretical distribution of substitutions detected in each cluster, as suggested in a different context in Van den Eynden and Larsson (2017).

Interestingly, the corrected dN/dS ratio computed on the genome coding regions (i.e., = 29133 basis) is equal to 0.84, 0.84 and 0.87, for the three signature-based clusters, respectively, and suggests the existence of purifying selection for all signature-related mutational processes.

We refined the analysis via a 300-base sliding window approach. On the one hand, the analysis of the mutational density confirms that the large majority of variants is indeed observed in purified regions of the genome. On the other hand, however, the variation of the corrected dN/dS ratio across the genome shows that some regions exhibit a ratio significantly larger than 1. This phenomenon, which is particularly evident in signature-based clusters SC#1 and SC#2, hints at possible positive selection processes affecting specific genomic regions and deserves further investigations.

Phylogenomic model of SARS-CoV-2 reveals transmission of minor variants and homoplasies. We employed VERSO (Ramazzotti et al., 2020) to reconstruct a robust phylogeny of samples from the binarized VF profiles of the 28 clonal variants (VF > 90%) detected in at least 3% of the dataset. In Fig. 5A one can see the output phylogenetic tree, which describes the existence of 23 clades and in which samples with identical corrected clonal genotype are grouped in polytomies (see Fig. 5B Interestingly, SNV g.29095T>C (mapped on ORF N, synonymous) appears to be the earliest evolutionary event from reference genome SARS-CoV-2-ANC (Ramazzotti et al., 2020) . All downstream clades belong to type B type (Forster et al., 2020; Tang et al., 2020) , as determined by presence of mutations g.8782T>C (ORF1ab, synonymous) and g.28144C>T (ORF1ab, p.84S>L). Importantly, we note that variant g.23403A>G (S, p.614D>G), whose correlation with viral transmissibility was investigated in depth (Lokman et al., 2020; Daniloski et al., 2020; Korber et al., 2020; Zhou et al., 2020a; Grubaugh et al., 2020; Plante et al., 2020) , is found in 18 clades, which include 1113 samples of the dataset.

In addition, the model unveils the presence of a number of homoplasies, as a few clonal variants are observed in independent clades and, especially, mutation g.11083G>T (ORF1ab, p.3606L>F), which was investigated in a number of recent studies on SARS-CoV-2 evolution (van Dorp et al., 2020; Ramazzotti et al., 2020) , and is observed in 42 samples and 8 distinct clades. One might hypothesize that such SNVs have spontaneously emerged in unrelated samples and were selected either due to some functional advantage or, alternatively to the combination of founder and stochastic effects involved in variant transmission during infections, which might lead certain minor SNVs transiting to clonality in the population (see above).

As extensively discussed in Ramazzotti et al. (2020) , while all the clonal variants of a host are most likely transmitted during an infection, the extent of transmission of minor variants is still baffling and is highly influenced by bottlenecks, founder effects and stochasticity (Gutierrez et al., 2012; Domingo et al., 2012) . Simultaneous infections of the same host from multiple individuals harboring distinct viral lineages (also named superinfections), might in principle affect variant clonality, yet their occurrence is extremely rare (Lythgoe et al., 2020) . For this reason, we quantified the number of minor variants (VF ≤ 90%):

1. privately detected in single samples, and which are most likely spontaneously emerged via host-related mutational processes;

2. found in multiple samples of the same clade, which might be either (a) spontaneously emerged or (b) transferred from other hosts via infection chains;

3. observed in multiple samples of independent clades (i.e., homoplasies), and which might be due to (a) positive selection of the variants due to some functional advantage, in a scenario of parallel/convergent evolution, (b) mutational hotspots, i.e., SVNs falling in mutation-prone sites or regions of the viral genome, (c) phantom mutations due to sequencing artifacts (Bandelt et al., 2002) , (d) complex transmission dynamics involving founder effects and stochasticity, which may allow certain minor variants to transit to clonality, eventually leading to a clonal genotype transmutation (see above).

In our case, we observe that 87.4% of minor variants are observed as private of single samples, 2.4% in multiple samples of the same clade and 10.2% are detected in samples belonging to distinct clades (Fig. 5E) . Importantly, significantly different VF distributions are observed and, especially, an approximately monotonic decrease of the median VF is detected with respect to the number of clades in which minor variants are found (Fig. 5D ). Important conclusions can be drawn from these results.

Apparently, the large majority of minor SVNs spontaneously emerges in single samples, likely due to signature-based mutational processes. Yet, the VF distribution of private minor SNVs suggests that, as expected, most of such variants are indeed purified in the population.

Accordingly, the hypothesis of transmission of minor variants during infections is supported by the significantly larger VF of (the fewer) minor variants found in multiple samples of the same clade, as this effect is most likely due to transmission bottleneck effects (Gutierrez et al., 2012; Domingo et al., 2012) .

In addition, the progressively smaller VF of minor variants observed in samples of independent clades, and which are likely more distant in the infection chain, hints at the noteworthy presence of mutational hotspots and of phantom mutations related to sequencing artifacts (Bandelt et al., 2002) . In all scenarios, the presence of positively selected variant cannot be excluded, but requires ad hoc investigations.

Interestingly, one can refine the analysis by focusing on distinct signature-based clusters, for instance, by pinpointing variants likely related to mutational hotspots or phantom mutations: see, e.g., variant g.8651A>C (ORF1ab, p.2796M>L) which is observed in 63 samples and 12 clades ( Figure 5C ).

Validation -Datasets #2 − 5

We employed 4 independent datasets (NCBI BioProjects: PRJNA625551, PRJNA633948, PRJNA636748 and PRJNA647529; see Methods for details), to validate the presence of the discovered mutational signatures. Specifically, we performed signature assignment with respect to the discovered signatures on 141, 23, 17 and 14 high-quality samples showing ≥ 6 always minor variants in each dataset, respectively.

Three signature-based clusters are found for all datasets and explain more that 97% of the variance in all cases, with highly significat p-values (see Fig. 6 ). Such clusters are related to combinations of signatures consistently to the analysis presented in the text and display alike distributions of minor SVNs (see Supplementary Fig. S6 ).

These important results prove the generality of our findings and strongly supports the hypothesis of distinct mutational processes active in distinct groups of samples.

Standard (phylo)genomic analyses of viral consensus sequences might miss useful information to investigate the elusive mechanisms of viral evolution within hosts and of transmission among hosts. In this respect, raw sequencing data of viral samples can be effectively employed to deliver a high-resolution picture of intra-host heterogeneity, which might underlie different clinical outcomes and affect the efficacy of anti-viral therapies. This aspect is vital especially during the critical phases of an outbreak, as experimental hypotheses are urgently needed to deliver effective prognostic, diagnostic and therapeutic strategies for infected patients.

We here presented one of the largest up-to-date quantitative analyses of intra-host genomic diversity of SARS-CoV-2, which revealed that the large majority of samples present a complex genomic composition, likely due to the interplay between host-related mutational processes and transmission dynamics.

In particular, we here proved the existence of mutually exclusive viral mutational signatures, i.e., nucleotide substitution patterns, which show that different hosts respond to SARS-CoV-2 infections in different ways, likely ruled by APOBEC, ROS or ADAR-related processes.

The corrected-for-signatures dS/dN analysis shows that such numerous low-frequency variants tend to be purified in the population whereas, conversely, a certain number of variants appear to consolidate. In particular, due to the still obscure combination of bottleneck effects and selection phenomena, certain variants appear to transit to clonality in the population, eventually leading to the definition of new clonal genotypes. Once become clonal, mutations tend to accumulate in the population, as proven by a statistically significant increase of genomic diversity, and might be used to reconstruct robust models of viral evolution via standard phylogenetic approaches.

The analysis of homoplasies, i.e., minor variants shared across distinct clades and unlikely due to infection events, demonstrate that a high number of mutations can independently emerge in multiple samples, due to mutational hotspots often related to signatures or, possibly, to positive (functional) selection. In addition, the relatively higher VF of minor variants shared by multiple samples of the same clades supports the hypothesis of transmission during infections.

To conclude, we advocate the release of a larger number of raw sequencing datasets, especially in combination with clinical data, in order to investigate the relation among the discovered host-specific processes and clinical outcome.

Reference genome. Different reference genomes have been employed for variant calling in the investigation of the origin and evolution of SARS-CoV-2. For instance, sequence EPI_ISL_405839 was used, e.g., in Bastola et al. (2020) and sequence EPI_ISL_402125, e.g., in Andersen et al. (2020) . As detailed in the Methods section, here we employed as reference the sequence SARS-CoV-2-ANC, which was identified in Ramazzotti et al. (2020) as a likely ancestral SARS-CoV-2 genome. Clearly, the use of different, albeit mostly overlapping, reference genomes can influence downstream analyses and, especially, the inference of the first evolutionary steps of the phylogenomic model, which should be therefore considered with caution. However, in our specific case, the employment of any of such reference genomes does not impact the identification and characterization of mutational signatures, since the SNVs that distinguish such sequences are found as clonal in at least one sample of the dataset and, accordingly, are excluded from the analysis.

Quasispecies composition. As discussed in the Introduction section, the analysis of raw sequencing data might be used to characterize the quasispecies architecture of single samples. To this end, a plethora of sophisticated computational methods for the characterization of the quasispecies composition of single samples is available, e.g., (Prosperi and 7 J o u r n a l P r e -p r o o f Salemi, 2012; Giallonardo et al., 2014; Töpfer et al., 2014; Barik et al., 2018) and was recently reviewed in Knyazev et al. (2020) . In the phylogenomic analysis included in this work, we decided to restrict the analysis on clonal variants that, by definition, are present in most of (or all) the quasispecies of a given sample. This allows us to provide a coarse-grained picture of the main steps of SARS-CoV-2 evolution and, at the same time, to investigate the possible transmission of minor variants, which are related to scarcely prevalent and rare quasispecies. It would be worth investigating how the combination of more sophisticated methods for quasispecies deconvolution and of our approach for mutational signatures analysis may improve the overall comprehension of SARS-CoV-2 diversity, adaptability and evolution.

Dataset quality. It was recently noted that some currently available SARS-CoV-2 datasets might present quality issues, especially with respect to low-frequency variants (De Maio et al., 2020) . For this reason, the results of any computational pipeline should be, in principle, validated on datasets for which the ground truth is known. In our case, and given the current shortage of SARS-CoV-2 benchmark datasets, we decided to validate the discovery and characterization of the mutational signatures on 4 different datasets, generated from independent laboratories worldwide, so to ensure the generality of the results obtained via our framework (see the Validation Section).

Indels. The evolution of SARS-CoV-2 is characterized by the presence of a significant number of insertions and deletions (Koyama et al., 2020) , which are being catalogued via COV-Glue (Singer et al., 2020) . In this work, we focused on the analysis of single-nucleotide variants, as this allows us to discover and characterize statistically significant host-related mutational signatures. Despite being beyond of the scope of the current work, it might be worth investigating the origination, evolution and transmission of indels as well.

Lead Contact 

This study did not generate new unique reagents.

The source code used to replicate all the analyses is available at this link: https://github.com/BIMIB-DISCo/SARS-CoV-2-IHMV. VERSO can be downloaded at this link: https://github.com/BIMIB-DISCo/VERSO. Additional Supplemental Items are available from Mendeley Data at: http://dx.doi.org/10.17632/vwc9jx5jfm.1. Week ( .71 (2220)

.03 (34) .06 (23) .02 (49) .08

.66

.14 (4277)

. 01 (199) B n = 20 n = 131 n = 214 n = 59 n = 58 n = 234 n = 180 n = 159 n = 78 10 20 < 1 6 1 6 − 1 8 1 9 − 2 1 2 2 − 2 4 2 5 − 2 7 2 8 − 3 0 3 1 − 3 3 3 4 − 3 6 3 7 − 3 9

Week ( J o u r n a l P r e -p r o o f

The repertoire of mutational signatures in human cancer

Signatures of mutational processes in human cancer

The proximal origin of SARS-CoV-2

The fingerprint of phantom mutations in mitochondrial DNA data

QSdpR: Viral quasispecies reconstruction via correlation clustering

The first 2019 novel coronavirus case in Nepal

Metagenes and molecular pattern discovery using matrix factorization

Molecular characterization of SARS-CoV-2 from the first case of COVID-19 in italy

Topology of viral evolution

The D614G mutation in SARS-CoV-2 spike increases transduction of multiple human cell types

Base-excision repair of oxidative DNA damage

Issues with SARS-CoV-2 sequencing data

Genomic surveillance reveals multiple introductions of SARS-CoV-2 into northern california

Evidence for host-dependent RNA editing in the transcriptome of SARS-CoV-2

The quasispecies (extremely heterogeneous) nature of viral RNA genome populations: biological relevance-a review

Viral quasispecies evolution. Microbiol

Phylogenetic network analysis of SARS-CoV-2 genomes

Full-length haplotype reconstruction to infer the structure of heterogeneous virus populations

Transmission dynamics and evolutionary history of 2019-nCoV

Exploring the genomic and proteomic variations of SARS-CoV-2 spike glycoprotein: a computational biology approach

Genomic epidemiology of SARS-CoV-2 in guangdong province, china

Viral escape mechanisms-escapology taught by viruses

Shared SARS-CoV-2 diversity suggests localised transmission of minority variants

Reactive oxygen and nitrogen species during viral infections

Intra-host dynamics of ebola virus during

Functions and regulation of RNA editing by ADAR deaminases

Rapid viral quasispecies evolution: implications for vaccine and drug strategies

Analysis of intrapatient heterogeneity uncovers the microevolution of middle east respiratory syndrome coronavirus

Spike mutation D614G alters SARS-CoV-2 fitness

Quantifying influenza virus diversity and transmission in humans

Genomic epidemiology of superspreading events in austria reveals mutational dynamics and transmission properties of SARS-CoV-2

QuRe: software for viral quasispecies reconstruction from next-generation sequencing data

VERSO: a comprehensive framework for the inference of robust phylogenies and the quantification of intra-host genomic diversity of viral samples

A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology

RNA viruses: ROS-mediated cell death

MrBayes 3.2: Efficient Bayesian Phylogenetic Inference and Model Choice Across a Large Model Space

Intra-host sitespecific polymorphisms of SARS-CoV-2 is consistent across multiple samples and methodologies

Tracking the covid-19 pandemic in australia using genomics

Apobec3a cytidine deaminase induces rna editing in monocytes and macrophages

Genomic diversity of SARS-CoV-2 in coronavirus disease 2019 patients

GISAID: Global initiative on sharing all influenza data-from vision to reality

Rampant c→ u hypermutation in the genomes of SARS-CoV-2 and other coronaviruses: Causes and consequences for their short-and long-term evolutionary trajectories

CoV-GLUE: a web application for tracking SARS-CoV-2 genomic variation

On the origin and continuing evolution of SARS-CoV-2

Coronavirus disease 2019 (COVID-19): situation report

Mutational signatures are critical for proper estimation of purifying selection pressures in cancer somatic mutation data when using the dn/ds metric

Emergence of genomic diversity and recurrent mutations in SARS-CoV-2

Virological assessment of hospitalized patients with COVID-2019

Cytosine deamination and selection of cpg suppressed clones are the two major independent biological forces that shape codon usage bias in coronaviruses

A new coronavirus associated with human respiratory disease in China

Isolation of SARS-CoV-2-related coronavirus from malayan pangolins

Sars-associated coronavirus quasispecies in individual patients

SARS-CoV-2 spike D614G variant confers enhanced replication and transmissibility

A pneumonia outbreak associated with a new coronavirus of probable bat origin

This work was partially supported by the Elixir Italian Chapter and the SysBioNet project, a Ministero dell'Istruzione, dell'Università e della Ricerca initiative for the Italian Roadmap of European Strategy Forum on Research Infrastructures and by the AIRC-IG grant 22082. We thank Marco Antoniotti, Giulio Caravagna, Chiara Damiani, Lucrezia Patruno and Francesco Craighero for helpful discussions.

A.G., D.M., F.A., R.P. and D.R. designed and developed the study. A.G, D.M., F.A. and D.R defined, implemented and executed the computational analyses. A.G., D.M., F.A., R.P. and D.R. analyzed the data and interpreted the results. A.G., D.R. and R.P. supervised the study. All authors wrote the manuscript, discussed the results, and commented on the manuscript.

The authors declare that they have no competing interests. 8 J o u r n a l P r e -p r o o f